Physiological monitoring and control in hemodialysis: State of the art and outlook

Expert Review of Medical Devices

Volumn 3, Issue 5, 2006, Pages 617-634

  Kraemer, Matthias ^a  

^a Fresenius Biotech   (Germany)

Author keywords

Automation; Bioimpedance; Dialysis; Expert systems; Feedback control; Fluid status; Hypotension; Monitoring; Optical sensors; Ultrasound sensors; Uremic toxins

Indexed keywords

CITRATE CALCIUM; ERYTHROPOIETIN; HEPARIN;

ABNORMAL SUBSTRATE CONCENTRATION IN BLOOD; ALKALOSIS; ANEMIA; ARTERIOVENOUS FISTULA; AUTOMATION; BLOOD FLOW; CANNULA; COST BENEFIT ANALYSIS; DEVELOPMENT; ELECTRICAL PARAMETERS; EQUIPMENT DESIGN; EXTRACORPOREAL CIRCULATION; FEEDBACK SYSTEM; FUTUROLOGY; HEMODIALYSIS; HUMAN; HYPOKALEMIA; KIDNEY FAILURE; MARKETING; MEDICAL INSTRUMENTATION; MEDICAL PARAMETERS; MORBIDITY; MORTALITY; ONLINE MONITORING; PATHOPHYSIOLOGY; PATIENT MONITORING; PATIENT SAFETY; REVIEW; SENSOR; SOUND; TEMPERATURE MEASUREMENT; THERAPY EFFECT; UNSPECIFIED SIDE EFFECT; VASCULAR ACCESS; VELOCITY;

BLOOD PRESSURE; BLOOD VOLUME; BODY TEMPERATURE; DIAGNOSIS, COMPUTER-ASSISTED; HUMANS; KIDNEY FAILURE, CHRONIC; MONITORING, PHYSIOLOGIC; RENAL DIALYSIS;

EID: 33750471588     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.3.5.617     Document Type: Review

References (112)

1. Daugirdas JT, Ing TS, Blake PG. Handbook of Dialysis, Third edition. Lippincott Williams & Wilkins (2000).
2. Polaschegg H-D, Levin NW. Hemodialysis machines and monitors, chap. 14. In: Replacement of Renal Function by Dialysis, 5th Edition. Hörl WH, Koch K-M, Lindsay RM, Ronco C, Winchester JF (Eds). Kluwer Academic Publishers, Dordrecht/Boston/London, 325-449 (2004).
3. Polaschegg H-D. The extracorporeal circuit. Semin. Dial. 8, 299-304 (1995).
4. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N. Engl. J. Med. 341, 1725-1730 (1999).
5. Pierratos A, McFarlane P, Chan CT. Quotidian dialysis - update 2005. Curr. Opin. Nephrol. Hypertens. 14, 119-124 (2005).
6. Kraemer M. Wiederherstellung von Nierenfunktionen, chap. 4. In: Kooperative und autonome Systeme der Medizintechnik: Funktionswiederherstellung und Organersatz. Werner J (Ed.). Oldenbourg Verlag München Wien, 277-347 (2005).
7. Schneditz D. Technologic aspects of hemodialysis and peritoneal dialysis, chap. 3. In: Clinical Dialysis, 4th Edition. Nissenson AR, Fine RN (Eds). The McGraw Hill Companies, Inc., 47-85 (2005).
8. Lindsay RM, Schneditz D. Online monitoring and feedback-control, chap. 20. In: Replacement of Renal Function by Dialysis, 5th Edition. Hörl WH, Koch K-M, Lindsay RM, Ronco C, Winchester JF (Eds). Kluwer Academic Publishers, Dordrecht/Boston/London, 555-584 (2004).
9. Akoh JA, Hakim NS. Dialysis Access: Current Practice. Imperial College Press, London, UK (2001).
10. Depner TA, Rizwan S, Cheer AY, Wagnet JM, Eder LA. High venous urea concentrations in the opposite arm. ASAIO Trans. 37, M141-M143 (1991).
11. Steuer RR, Bell DA, Barrett LL. Optical measurement of hematocrit and other biological constituents in renal therapy. Adv. Ren. Replace. Ther. 6, 217-224 (1999).
12. Krivitski NM. Theory and validation of access flow measurement by dilution technique during hemodialysis. Kidney Int. 48, 244-250 (1995).
13. Krivitski NM, MacGibbon D, Gleed RD, Dobson A. Accuracy of dilution techniques for access flow measurement during hemodialysis. Am. J. Kidney Dis. 31, 502-508 (1998).
14. Kraemer M, Polaschegg H-D. Automated measurement of recirculation. EDTNA-ERCA. J. XIX, 8-15 (1993).
15. Wang E, Schneditz D, Kaufman AM, Levin NW. Sensitivity and specificity of the thermodilution technique in detection of access recirculation. Nephron 85, 134-141 (2000).
16. Lopot F, Nejedly B, Sulkova S, Blaha J. Comparison of different techniques of hemodialysis vascular access flow evaluation. Int. J. Artif. Organs 26, 1056-1063 (2003).
17. Schneditz D, Wang E, Levin NW. Validation of haemodialysis recirculation and access blood flow measured by thermodilution. Nephrol. Dial. Transplant. 14, 376-383 (1999).
18. III. NKF-DOQI Clinical Practice Guidelines for Vascular Access: Update 2000. NY, USA (2004).
19. Tonelli M, Jindal K, Hirsch D, Taylor S, Kane C, Henbrey S. Screening for subclinical stenosis in native vessel arteriovenous fistulae. J. Am. Soc. Nephrol, 12, 1729-1733 (2001).
20. Paulson WD, Ram SJ, Birk CG, Zapczinski M, Martin SR, Work J. Accuracy of decrease in blood flow in predicting hemodialysis graft thrombosis. Am. J. Kidney Dis. 37, 451-452 (2001).
21. May RE, Himmelfarb J, Yenicesu M et al. Predictive measures of vascular access thrombosis: a prospective study. Kidney Int. 52, 1656-1662 (1997).
22. Engelberts I, Tordoir JH, Boon ES, Schreij G. High-output cardiac failure due to excessive shunting in a hemodialysis access fistula: an easily overlooked diagnosis. Am. J. Nephrol. 15, 323-326 (1995).
23. Steuer RR, Miller DR, Zhang S, Bell DA, Leypoldt JK. Noninvasive transcuraneous determination of access blood flow rate. Kidney Int. 60, 284-291 (2001).
24. Mercadal L, Hamani A, Béné B, Petitclerc T. Determination of access blood flow from ionic dialysance: theory and validation. Kidney Int. 56, 1560-1565 (1999).
25. Lindsay RM, Burbank J, Brugger J et al. A device and a method for rapid and accurate measurement of access recirculation during hemodialysis. Kidney Int. 49, 1152-1160 (1996).
26. Kleinekofort W, Kraemer M, Rode C, Wizemann V. Extracorporeal pressure monitoring and the detection of vascular access stenosis. Int. J. Artif. Organs 25, 45-50 (2002).
27. Besarab A, Al-Saghir F, Alnabhan N, Lubkowski T, Frinak S. Simplified measurement of intra-access pressure. ASAIO J. 42, M682-M687 (1996).
28. Polaschegg H-D, Techert F, Wizemann V. Dynamic pressure measurement for detection of blood access stenosis. EDTNA-ERCA J. 24(4), 39-44 (1998).
29. Ciandrini A, Lodi CA, Galato R, Miscia MC, Cavalcanti S. On-line evaluation of vascular access flow in hemodialysis patients. (abstract) Int. J. Artif. Organs 28, 897 (2005).
30. Besarab A. Access monitoring is worthwile and valuable. Blood Purif. 24, 77-89 (2006).
31. Depner TA. Hemodialysis adequacy: basic essentials and practical points for the nephrologist in training. Hemodial. Int. 9, 241-254 (2005).
32. Greene T, Depner TA, Daugirdas JT et al. Association of achieved dialysis dose with mortality in the hemodialysis study: an example of "dose-targeting bias". J. Am. Soc. Nephrol. 16, 3371-3380 (2005).
33. Vanholder R, De Smet R, Glorieux G et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int. 63(5), 1934-1943 (2003).
34. Vanholder R, Glorieux G, Lameire N. New insights in uremic toxicity. Contrib. Nephrol. 149, 315-324 (2005).
35. NKF-DOQI. Clinical practice guidelines for hemodialysis adequacy: update 2000. Nephrol. Dial. Transplant. 37, S7-S64 (2001).
36. European best practice guidelines expert group on hemodialysis, European Renal Association. Section II. Hemodialysis adequacy. Nephrol. Dial. Transplant. 17, 16-31 (2002).
37. Depner TA. Prescribing Hemodialysis: A Guide To Urea Modeling Kluwer Academic Publishers (1991).
38. Depner TA. Quantifying hemodialysis. Am. J. Nephrol. 16, 17-28 (1996).
39. Argiles; A, Ficheux A, Thomas M et al. Precise quantification of dialysis using continuous sampling of spent dialysate and total dialysate volume measurement. Kidney Int. 52, 530-537 (1997).
40. Calzavara P, Calconi G, Canini E, Paolini F. A new biosensor for continuous monitoring of the spent dialysate urea level in standard hemodialysis. Int. J. Artif. Organs 21, 147-150 (1998).
41. Depner TA, Keshaviah P, Ebben JP et al. Multicenter clinical validation of an on-line monitor of dialysis adequacy. J. Am. Soc. Nephrol. 7, 464-471 (1996).
42. Bosticardo GM, Avalle U, Giacchino F, Molino A, Alloatti S. Accuracy of an on-line urea monitor compared with urea kinetic model and direct dialysis quantification. ASAIO J. 40, M426-M430 (1994).
43. Colasanti G, Arrigo G, Santoro A et al. Biochemical aspects and clinical perspectives of continuous urea monitoring in plasman ultrafiltrate. Int. J. Artif. Organs 18, 544-547 (1995).
44. Polaschegg H-D. Automatic, noninvasive intradialytic clearance measurement. Int. J. Artif. Organs 16, 185-191 (1993).
45. Petitclerc T, Goux N, Reynier AL, Bene B. A model for non-invasive estimation of in vivo dialyzer performances and patient's conductivity during hemodialysis. Int. J. Artif. Organs 16, 585-591 (1993).
46. Gotch F. On-line clearance: advanced methodology to monitor adequacy of dialysis at no cost. Contrib. Nephrol. 137, 268-271 (2002).
47. Gotch FA, Panlilio F, Buyaki R, Wang E, Folden T, Levin NW. Mechanisms determining the ratio of conductivity clearance to urea clearance. Kidney Int. Suppl. 89, S3-S24 (2004).
48. Locatelli F, Buoncristiani U, Canaud B, Köhler H, Petitclerc T, Zucchelli P. Hemodialysis with on-line monitoring equipment: tools or toys? Nephrol. Dial. Transplant. 20, 22-33 (2005).
49. Uhlin F, Fridolin I, Lindberg LG, Magnusson M. Estimation of delivered dialysis dose by on-line monitoring of the ultraviolet absorbance in the spent dialysate. Am. J. Kidney Dis. 41, 1026-1036 (2003).
50. Snoer Jensen P, Bak J, Ladefoged S, Andersson-Engels S, Friis-Hansen L. Online monitoring of urea concentration in dialysate with dual-beam Fourier-transform near-infrared spectroscopy. J. Biomed. Opt. 9, 553-557 (2004).
51. Olesberg JT, Arnold MA, Flanigan MJ. Online measurement of urea concentration in spent dialysate during hemodialysis. Clin. Chem. 50, 175-181 (2004).
52. Kraemer M, Rode C, Wizemann V. Detection limit of methods to assess fluid status changes in dialysis patients. Kidney Int. 69, 1609-1620 (2006).
53. Fishbane S, Natke E, Maesaka JK. Role of volume overload in dialysis-refractory hypertension. Am. J. Kidney Dis. 28, 257-261 (1996).
54. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE. Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int. 49, 1379-1385 (1996).
55. Parfrey PS. Pathogenesis of cardiac disease in dialysis patients. Semin. Dial. 12, 62-68 (1999).
56. Charra B. Dry weight in dialysis: the history of a concept. Nephrol. Dial. Transplant. 13, 1882-1885 (1998).
57. Jaeger JQ, Mehta RL. Assessment of dry weight in hemodialysis: an overview. J. Am. Soc. Nephrol. 10, 392-403 (1999).
58. Kouw PM, Kooman JP, Cheriex EC, Olthof CG, de Vries PM, Leunissen KML. Assessment of postdialysis dry weight: a comparison of techniques. J. Am. Soc. Nephrol. 4, 98-104 (1993).
59. Wizemann V, Schilling M. Dilemma of assessing volume state - the use and the limitations of a clinical score. Nephrol. Dial. Transplant. 10, 2114-2117 (1995).
60. Ando Y, Yanagiba S, Asano Y. The inferior vena cava diameter as a marker of dry weight in chronic hemodialyzed patients. Artif. Organs 12, 1237-1242 (1995).
61. Kusaba T, Yamaguchi K, Oda H. Echography of the inferior vena cava for estimating fluid removal from patients undergoing hemodialysis. Jpn J. Nephrol. 38, 119-123 (1996).
62. Oe B, de Fijter CW, Geers TB, Vos PF, Donker ABJ, de Vries PM. Diameter of inferior caval vein and impedance analysis for assessment of hydration status in peritoneal dialysis. Artif. Organs 24, 575-583 (2000).
63. Zhu F, Kuhlmann U, Sarkar S et al. Adjustment of dry weight in hemodialysis patients using intradialytic continuous multifrequency bioimpedance of the calf. Int. J. Artif. Organs 27, 104-109 (2004).
64. Zhu F, Sarkar S, Kaiwatcharachai C, Greenwood R, Ronco C, Levin NW. Methods and reproducibility of measurement of resistivity in the calf using regional bioimpedance analysis. Blood Purif. 21, 131-136 (2003).
65. Ward L, Cornish BH, Paton NI, Thomas BJ. Multiple frequency bioelectrical impedance analysis: a cross-validation study of the inductor circuit and cole models. Physiol. Meas. 20, 333-347 (1999).
66. Gudivaka R, Schoeller DA, Kushner RF, Bolt JG. Single- and multifrequency models for bioelectrical impedance analysis of body water compartments. J. Appl. Physiol. 87, 1087-1096 (1999).
67. van Loan MD, Withers PO, Matthie JR, Mayclin PL. Use of bioimpedance spectroscopy to determine extracellular fluid, intracellular fluid, total body water, and fat-free mass. In: Human Body Composition. Ellis KJ, Eastman JD. (Eds), Plenum Press, NY, USA, 67-70 (1993).
68. Patel RV, Matthie JR, Withers PO, Peterson EL, Zarowitz BJ. Estimation of total body and extracellular water using single- and multiple-frequency bioimpedance. Ann. Pharmacother. 28, 565-569 (1994).
69. van Marken Lichtenbeld WD, Westerterp KR, Wouters L, Luijendijk SC. Validation of bioelectrical-impedance measurements as a method to estimate body-water compartments. Am. J. Clin. Nutr. 60, 159-166 (1994).
70. Chamney P, Kraemer M, Rode C, Kleinekofort W, Wizemann V. A new technique for establishing dry weight in hemodialysis patients via whole body bioimpedance. Kidney Int. 61, 2250-2258 (2002).
71. Katzarski K, Charra B, Laurent G et al. Multifrequency bioimpedance in assessment of dry weight in haemodialysis. Nephrol. Dial. Transplant. 11, 20-23 (1996).
72. Fisch BJ, Spiegel DM. Assessment of excess fluid distribution in chronic hemodialysis patients using bioimpedance spectroscopy. Kidney Int. 49, 1105-1109 (1996).
73. Kraemer M. A new model for determination of fluid status and body composition from bioimpedance measurements. Physiol. Meas. 27, 901-919 (2006).
74. Chertow GM. Assessing the nutritional status of patients with end-stage renal disease. Semin. Dial. 10, 108-114 (1997).
75. Barbosa-Silva MCG, Barros AJD, Post CLA, Waitzberg DL, Heymsfield SB. Can bioelectrical impedance analysis identify malnutrition in preoperative nutrition assessment? Nutrition 19(5), 422-426 (2003).
76. Marcen R, Teruel JL, de la Cal MA, Gamez C. The impact of malnutrtion in morbidity and mortality in stable haemodialysis patients. Nephrol. Dial. Transplant. 12, 2324-2331 (1997).
77. Daugirdas JT. Preventing and managing hypotension. Semin. Dial. 7, 276-283 (1994).
78. Converse RL, Jacobsen TN, Jost CH et al. Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialyis-induced hypotension. J. Clin. Invest. 90, 1657-1665 (1992).
79. Schmidt R, Roeher O, Hickstein H, Korth S. Prevention of haemodialysis-induced hypotension by biofeedback control of ultrafiltration and infusion. Nephrol. Dial. Tansplant. 16, 595-603 (2001).
80. Schneditz D, Levin NW. Non-invasive blood volume monitoring during hemodialysis: technical and physiological aspects. Semin. Dial. 10, 166-169 (1997).
81. de Vries JP, Donker AJM, de Vries PM. Prevention of hypovolemia-induced hypotension during hemodialysis by means of an optical reflection method. Int. J. Artif. Organs 17, 209-214 (1994).
82. Schallenberg U, Stiller S, Mann H. A new method of continuous haemoglobinometric measurement of blood volume during haemodialysis. Life Support Syst. 5, 293-305 (1987).
83. Hinghofer-Szalkay H, Greenleaf JE. Continuous monitoring of blood volume changes in humans. J. Appl. Physiol. 63(3), 1003-1007 (1987).
84. Schneditz D, Pogglitsch H, Horina J, Binswanger U. A blood protein monitor for the continuous measurement of blood volume changes during hemodialysis. Kidney Int. 38, 342-346 (1990).
85. Johner C, Chamney P, Schneditz D, Kraemer M. Evaluation of an ultrasonic blood volume monitor. Nephrol. Dial. Transplant. 13, 2098-2103 (1998).
86. de Vries PM, Kouw PM, Meijer JH, Oe LP, Schneider H, Donker ABJ. Changes in blood parameters during hemodialysis as determined by conductivity measurements. ASAIO Trans. 29, 623-626 (1988).
87. Greenwood R, Aldridge C, Cattell WR. Serial blood water estimations and in-line blood viscometry: the continuous measurement of blood volume during dialysis. Clin. Sci. 66, 583 (1984).
88. Kuhlmann U, Buren FV, Aziz O, Lange H. On-line monitoring of intravascular volume during haemodialysis by continuous refractometry. Int. J. Artif. Organs 22, 205-209 (1999).
89. Steuer RR, Leypoldt JK, Cheung AK, Senekjian HO, Conis JM. Reducing symptoms during hemodialysis by continuously monitoring the hematocrit. Am. J. Kidney Dis. 27, 525-532 (1996).
90. Paolini F, Mancini E, Bosetto A, Santoro A. Hemoscan: a dialysis machine-integrated blood volume monitor. Int. J. Artif. Organs 18, 487-494 (1995).
91. Barth C, Boer W, Garzoni D et al. Characteristics of hypotension-prone hemodialysis patients: is there a critical relative blood volume? Nephrol. Dial. Transplant. 18, 1353-1360 (2003).
92. Kraemer M. New strategies for reducing intradialytic symptoms. Semin. Dial. 12, 389-395 (1999).
93. Schuemann E, Wojke R, Gauly A et al. Less intradialytic morbid events by automatic blood volume controlled ultrafiltration (abstract). Int. J. Artif. Organs 26, 652 (2003).
94. Basile C, Giordano R, Vernaglione L et al. Efficacy and safety of haemodialysis treatment with the hemocontrol biofeedback system: a prospective medium-term study. Nephrol. Dial. Transplant. 16, 328-334 (2001).
95. Santoro A, Mancini E, Basile C et al. Blood volume controlled hemodialysis in hypotension-prone patients: a randomized, multicenter controlled trial. Kidney Int. 62, 1034-1045 (2002).
96. Gotch FA, Keen ML, Yarian SR. An analysis of thermal regulation in hemodialysis with one and three compartment models. ASAIO Trans. 35, 622-624 (1989).
97. Schneditz D. Temperature and thermal balance in hemodialysis. Semin. Dial. 14, 357-364 (2001).
98. Kraemer M, Steil H, Polaschegg HD. Optimization of a sensor head for blood temperature measurement during hemodialysis. Proc. of the IEEE 14(4), 1610-1611 (1992).
99. Kraemer M, Polaschegg H-D. Control of blood temperature and thermal energy balance during hemodialysis. Proc. of the IEEE 14(4) (1992).
100. Maggiore Q, Pizzarelli F, Santoro A et al. The effects of control of thermal balance on vascular stability in hemodialysis patients: results of the European randomized clinical trial. Am. J. Kidney Dis. 40, 280-290 (2002).
101. Kaufman AM, Morris AT, Lavarias VA et al. Effects of controlled blood cooling on hemodynamic stability and urea kinetics during high-efficiency hemodialysis. J. Am. Soc. Nephrol. 9, 877-883 (1998).
102. Ketchersid TL, van Stone JC. Dialysate potassium. Semin. Dial. 4, 46-51 (1991).
103. Blumberg A, Roser HW, Zehnder C, Mueller-Brand J. Plasma potassium in patients with terminal renal failure during and after haemodialysis: relationship with dialytic potassium removal and total body potassium. Nephrol. Dial. Transplant. 12, 1629-1634 (1997).
104. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J. Am. Soc. Nephrol. 9, S16-S23 (1998).
105. Krivitski NM, Depner TA. Cardiac output and central blood volume during hemodialysis: methodology. Adv. Ren. Replace. Ther. 6, 225-232 (1999).
106. Strobeck JE, Silver MA, Ventura H. Impedance cardiography: noninvasive measurement of cardiac stroke volume and thoracic fluid content (editorial). Congest. Heart Fail. 6, 3-6 (2000).
107. De Maria AN, Raisinghani A. Comparative overview of cardiac output measurement methods: has impedance cardiography come of age? Congest. Heart Fail. 6, 7-18 (2000).
108. Greenberg BH, Hermann DD, Pranulis MF, Lazio L, Cloutier D. Reproducibility of impedance cardiography hemodynamic measures in clinically stable heart failure patients. Congest. Heart Fail. 6, 19-26 (2000).
109. Vilderrabano F, Hoerl WH, Jacobs C et al. European best practice guidelines 9-13: anaemia management. Nephrol. Dial. Tansplant. 15(Suppl. 4), 33-42 (2000).
110. Janssen MJ, Deegens JK, Kapinga TH et al. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients. Kidney Int. 49, 806-813 (1996).
111. Apsner R, Buchmayer H, Gruber D, Sunder-Plassmann G. Citrate for long-term hemodialysis: prospective study of 1,009 consecutive high-flux treatments in 59 patients. Am. J. Kidney Dis. 45, 557-564 (2005).
112. Ridel C, Mercadal L, Bene B, Hamani A, Deray G, Petitclerc T. Regional citrate anticoagulation during hemodialysis: a simplified procedure using Duocart biofiltration. Blood Purif. 23, 473-480 (2005).